Trastuzumab duocarmazine (Synonyms: (vic)-Trastuzumab duocarmazine) |
Catalog No.GC26478 |
Trastuzumab duocarmazine ((vic) - Trastuzumab duocarmazine) is a HER2 targeted ADC that can be recognized and cleaved by tissue protease B in tumor cells, selectively targeting tumor cells.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1642152-40-6
Sample solution is provided at 25 µL, 10mM.
Trastuzumab duocarmazine ((vic) - Trastuzumab duocarmazine) is a HER2 targeted ADC that can be recognized and cleaved by tissue protease B in tumor cells, selectively targeting tumor cells. Trastuzumab duocarmazine has anti-tumor activity and can be used for research on related cancers such as uterine and ovarian carcinosarcoma.
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *